| 标题 |
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者:Khattak A; Carlino MS; Meniawy T; Ansstas G; Taylor MH; et al 出版日期:2026/09/10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)